"We also have a lot less cash and prospects than back in 2011"Boysy1 but if the current prospect are positive won't that bring the options into play? Meaning more $$ for the company?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential